Developing COVID-19 vaccine’s trial paused following unexplained illness

Human trials of AstraZeneca’s developing COVID-19 vaccine have been stopped since one of the volunteers’ of the study reportedly got sick with an unexplained illness. The development was announced after one of the regular reviews of the vaccine trials.

AstraZeneca has currently paused the trails to examine safety data while maintaining the reliability of the trials. AstraZeneca spokeswoman Michele Meixell has explained the illness as a “routine action”. 

“This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials,” she said in a statement.

However, the Serum Institute of India that is developing a COVID-19 vaccine in the nation has informed that this new development will not halt the trials being conducted in India.

“This incident in the UK will have no impact on the Indian vaccine trial being carried out by Serum Institute,” said Adar Poonawalla, CEO of Serum Institute of India.

Total
0
Shares
Related Posts
Total
0
Share